Drug intelligence / Profile preview

phenylalanine

Development stage
Preclinical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Phenylalanine is an essential α-amino acid found naturally in many protein-rich foods and used as a dietary supplement. It exists in three forms: L-phenylalanine (the natural form incorporated into proteins), D-phenylalanine (a synthetic variant), and DL-phenylalanine (a racemic mixture). Phenylalanine is a precursor for tyrosine and subsequently for the neurotransmitters dopamine, norepinephrine, and epinephrine. Its mechanisms of action include serving as a substrate for neurotransmitter synthesis—potentially contributing to antidepressant effects—and stimulating the release of satiety hormones such as cholecystokinin (CCK) and peptide YY (PYY), which may regulate appetite. Phenylalanine also increases insulin and glucagon secretion, influencing glucose metabolism. In the brain, L-phenylalanine acts as an antagonist at NMDA receptor glycine binding sites and AMPA receptor glutamate binding sites; it can inhibit neurotransmitter release at glutamatergic synapses at high concentrations[1][6][8]. D-Phenylalanine has been proposed to treat chronic pain by inhibiting enkephalinase[5]. Phenylketonuria is a genetic disorder that impairs phenylalanine metabolism.

Other names
L-phenylalanineD-phenylalanineDL-phenylalaninePheF
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on phenylalanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phenylalanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call